RHUMBLINE ADVISERS - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$841,477
+36.6%
199,405
+0.3%
0.00%0.0%
Q2 2023$616,224
+273777.3%
198,782
+22.6%
0.00%
Q1 2023$225
-29.5%
162,185
+1.0%
0.00%
Q4 2022$319
-99.9%
160,513
+3.1%
0.00%
Q3 2022$314,000
-32.8%
155,651
+6.1%
0.00%
-100.0%
Q2 2022$467,000
-22.6%
146,721
+1.5%
0.00%0.0%
Q1 2022$603,000
-20.4%
144,582
-8.6%
0.00%0.0%
Q4 2021$758,000
-7.0%
158,222
+3.7%
0.00%0.0%
Q3 2021$815,000
+6.4%
152,534
+2.0%
0.00%0.0%
Q2 2021$766,000
-26.2%
149,596
-3.0%
0.00%0.0%
Q1 2021$1,038,000
+41.0%
154,250
-4.2%
0.00%0.0%
Q4 2020$736,000
+23.3%
161,043
+4.7%
0.00%0.0%
Q3 2020$597,000
-29.3%
153,753
-13.3%
0.00%0.0%
Q2 2020$844,000
+56.6%
177,243
+14.3%
0.00%0.0%
Q1 2020$539,000
-24.0%
155,006
+5.4%
0.00%0.0%
Q4 2019$709,000
+88.1%
147,019
+13.0%
0.00%0.0%
Q3 2019$377,000
-59.8%
130,147
-0.6%
0.00%
-50.0%
Q2 2019$938,000
-46.6%
130,892
+5.7%
0.00%
-33.3%
Q1 2019$1,755,000
+3.5%
123,850
-1.2%
0.00%
-25.0%
Q4 2018$1,695,000
-12.8%
125,310
+43.1%
0.00%0.0%
Q3 2018$1,944,000
+27.0%
87,597
-6.1%
0.00%
+33.3%
Q2 2018$1,531,00093,2820.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders